Nrx Pharmaceuticals logo

Nrx Pharmaceuticals Share Price Today

(NASDAQ: NRXP)

Nrx Pharmaceuticals share price is $2.14 & ₹186.11 as on 6 Mar 2025, 2.30 'hrs' IST

$2.14

0.02

(0.94%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Nrx Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Nrx Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Nrx Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Nrx Pharmaceuticals share price movements

  • Today's Low: $2.03
    Today's High: $2.15

    Day's Volatility :5.81%

  • 52 Weeks Low: $1.10
    52 Weeks High: $7.33

    52 Weeks Volatility :85.0%

Nrx Pharmaceuticals (NRXP) Returns

PeriodNrx Pharmaceuticals IncSector (Health Care)Index (Russel 2000)
3 Months
78.15%
2.1%
0.0%
6 Months
28.48%
-4.1%
0.0%
1 Year
-69.74%
2.2%
0.0%
3 Years
-91.52%
11.8%
-11.6%

Nrx Pharmaceuticals (NRXP) Key Statistics

in dollars & INR

Previous Close
$2.12
Open
$2.15
Today's High
$2.15
Today's Low
$2.025
Market Capitalization
$34.3M
Today's Volume
$21.3K
52 Week High
$7.333
52 Week Low
$1.1
Revenue TTM
$0.0
EBITDA
$-20.5M
Earnings Per Share (EPS)
$-2.11
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-682.61%

How to invest in Nrx Pharmaceuticals Stock (NRXP) from India?

It is very easy for Indian residents to invest directly in Nrx Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Nrx Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Nrx Pharmaceuticals or NRXP on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Nrx Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Nrx Pharmaceuticals shares which would translate to 0.406 fractional shares of Nrx Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Nrx Pharmaceuticals, in just a few clicks!

Returns in Nrx Pharmaceuticals (NRXP) for Indian investors in Rupees

The Nrx Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Nrx Pharmaceuticals investment value today

Current value as on today

₹35,491

Returns

₹64,509

(-64.51%)

Returns from Nrx Pharmaceuticals Stock

₹69,472 (-69.47%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Nrx Pharmaceuticals (NRXP)

-89%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Nrx Pharmaceuticals Stock from India on INDmoney has decreased by -89% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Nrx Pharmaceuticals

  • AdvisorShares Investments, LLC

    1.83%

  • Vanguard Group Inc

    1.42%

  • Anson Funds Management LP

    1.10%

  • Susquehanna International Group, LLP

    0.49%

  • Geode Capital Management, LLC

    0.44%

  • BlackRock Inc

    0.17%

Analyst Recommendation on Nrx Pharmaceuticals

Buy

    88%Buy

    11%Hold

    0%Sell

Based on 9 Wall street analysts offering stock ratings for Nrx Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
8
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Nrx Pharmaceuticals Stock (NRXP)

What analysts predicted

Upside of 1379.75%

Target:

$31.67

Current:

$2.14

Insights on Nrx Pharmaceuticals Stock (Ticker Symbol: NRXP)

  • Price Movement

    In the last 3 months, NRXP stock has moved up by 78.2%
  • NRXP vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 130.3%
  • NRXP vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 139.3%

Nrx Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Nrx Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

Nrx Pharmaceuticals (NRXP) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Nrx Pharmaceuticals Inc logo
-24.29%
28.48%
-69.74%
-91.52%
-91.26%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Nrx Pharmaceuticals Inc logo
0.36
NA
NA
-1.85
-6.83
-1.46
NA
-1.66
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Nrx Pharmaceuticals Inc logo
Buy
$34.3M
-91.26%
0.36
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Nrx Pharmaceuticals

NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders, including suicidal depression, post-traumatic stress disorder, and chronic pain. Its products include NRX-101 (D-cycloserine/Lurasidone), an oral, fixed dosed combination of D-cycloserine and lurasidone that earned food and drug administration-designated breakthrough therapy for suicidal treatment-resistant bipolar depression; and NRX-100 (ketamine), which has been awarded FDA fast track designation for the treatment of severe bipolar depression with acute suicidal ideation and behavior. The company has a partnership with Alvogen Inc. and Lotus Pharmaceutical Company; development and manufacturing agreement with Nephron Pharmaceuticals, Inc. and Alcami; license agreement with Apkarian Technologies; development and license agreement with Glytech; license agreement with Sarah Herzog Memorial Hospital. The company was founded in 2015 and is based in Wilmington, Delaware.
Organization
Nrx Pharmaceuticals
Employees
0
CEO
Mr. Matthew Patrick Duffy
Industry
Services

Management People of Nrx Pharmaceuticals

NameTitle
Dr. Jonathan C. Javitt M.D., M.P.H.
Co-Founder, Chief Scientist Officer, Chairman & Interim CEO
Mr. Richard Clavano Narido
Treasurer
Mr. Michael S. Abrams
Chief Financial Officer
Dr. Riccardo Panicucci Ph.D.
Chief Manufacturing & Technology Officer
Suzanne Messere
Investor Relations
Dr. Philip T. Lavin Ph.D.
Chief Methodologist
Mr. Matthew Patrick Duffy
Chief Business Officer & Co-CEO of Hope Therapeutics

Important FAQs about investing in NRXP Stock from India :

What is Nrx Pharmaceuticals share price today?

Nrx Pharmaceuticals share price today stands at $2.14, Open: $2.15 ; Previous Close: $2.12 ; High: $2.15 ; Low: $2.03 ; 52 Week High: $7.33 ; 52 Week Low: $1.10.

The stock opens at $2.15, after a previous close of $2.12. The stock reached a daily high of $2.15 and a low of $2.03, with a 52-week high of $7.33 and a 52-week low of $1.10.

Can Indians buy Nrx Pharmaceuticals shares?

Yes, Indians can invest in the Nrx Pharmaceuticals (NRXP) from India.

With INDmoney, you can buy Nrx Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Nrx Pharmaceuticals at zero transaction cost.

How can I buy Nrx Pharmaceuticals shares from India?

It is very easy to buy Nrx Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Nrx Pharmaceuticals (NRXP) be purchased?

Yes, you can buy fractional shares of Nrx Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Nrx Pharmaceuticals stocks?

To start investing in Nrx Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Nrx Pharmaceuticals Stock (NRXP)?

Today’s highest price of Nrx Pharmaceuticals (NRXP) is $2.15.

Today’s lowest price of Nrx Pharmaceuticals (NRXP) is $2.03.

What is today's market capitalisation of Nrx Pharmaceuticals?

Today's market capitalisation of Nrx Pharmaceuticals NRXP is 34.3M

What is the 52 Week High and Low Range of Nrx Pharmaceuticals Stock (NRXP)?

  • 52 Week High

    $7.33

  • 52 Week Low

    $1.10

What are the historical returns of Nrx Pharmaceuticals (NRXP)?

  • 1 Month Returns

    -24.29%

  • 3 Months Returns

    28.48%

  • 1 Year Returns

    -69.74%

  • 5 Years Returns

    -91.26%

Who is the Chief Executive Officer (CEO) of Nrx Pharmaceuticals ?

Mr. Matthew Patrick Duffy is the current Chief Executive Officer (CEO) of Nrx Pharmaceuticals.